【summary】
The UK is paying less for new cancer drugs than a number of other high-income countries.
while the UK,Greece,Spain and Portugal pay the least,on average,for the drugs they use,Germany,Sweden and Switzerland pay the most.
The report said drugs had accounted for nearly a third of the EU’s 51 billion euro cancer healthcare spending in 2009.
And the researchers then compared the 2013 price of 31 cancer drugs in 18 high-income countries,including the UK,Australia,New Zealand,France,Greece,Sweden and Portugal.
The price of drugs is determined by the Pharma Price Information service in Austria,which details what manufacturers charge per unit.
However, the official list prices published are freely available,any further discounts remain confidential.
The discounts should be open to everyone because they are overpaying.
【my opinion】
I think that opening information is important.Because it is unfair the secret that there are countries dosen’t know the information.I think they should be open the Pharma Price Information service in Austria,not remain confidential.